GSK Plc Valuation
| GLAXF Stock | USD 31.48 1.13 3.72% |
At this time, the firm appears to be overvalued. GSK plc retains a regular Real Value of $24.55 per share. The prevalent price of the firm is $31.48. Our model calculates the value of GSK plc from analyzing the firm fundamentals such as Return On Asset of 0.0659, operating margin of 0.25 %, and Return On Equity of 0.31 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GSK Plc's price fluctuation is not too volatile at this time. Calculation of the real value of GSK plc is based on 3 months time horizon. Increasing GSK Plc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GSK pink sheet is determined by what a typical buyer is willing to pay for full or partial control of GSK plc. Since GSK Plc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GSK Pink Sheet. However, GSK Plc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 31.48 | Real 24.55 | Hype 31.48 | Naive 32.19 |
The real value of GSK Pink Sheet, also known as its intrinsic value, is the underlying worth of GSK plc Company, which is reflected in its stock price. It is based on GSK Plc's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GSK Plc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GSK plc helps investors to forecast how GSK pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GSK Plc more accurately as focusing exclusively on GSK Plc's fundamentals will not take into account other important factors: About GSK Plc Valuation
The pink sheet valuation mechanism determines GSK Plc's current worth on a weekly basis. Our valuation model uses a comparative analysis of GSK Plc. We calculate exposure to GSK Plc's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GSK Plc's related companies.GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.
8 Steps to conduct GSK Plc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates GSK Plc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct GSK Plc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain GSK Plc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine GSK Plc's revenue streams: Identify GSK Plc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research GSK Plc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish GSK Plc's growth potential: Evaluate GSK Plc's management, business model, and growth potential.
- Determine GSK Plc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate GSK Plc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
GSK Plc Growth Indicators
Investing in growth stocks can be very risky. If the company such as GSK Plc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.1 B | |
| Quarterly Earnings Growth Y O Y | 0.97 | |
| Forward Price Earnings | 9.7087 | |
| Retained Earnings | 4.4 B |
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |